Table 1.
Clinical/demographics | N=215 |
Age, years | 68.6 ± 10.3 |
Body mass index, kg/m2 | 27.3 ± 4.4 |
Women, n (%) | 123 (57.2) |
Hypertension, n (%) | 150 (69.8) |
Diabetes, n (%) | 55 (25.6) |
Hypercholesterolemia, n (%) | 129 (60.0) |
CAD, n (%) | 5 (2.3) |
Echocardiographic data | |
LV end-diastolic diameter, mm/m2 | 26.1 ± 3.3 |
LV mass index, g/m2 | 104.6 ± 26.6 |
LV hypertrophy, n (%) | 87 (40.5) |
Relative wall thickness | 0.48 ± 0.08 |
LVEF, % | 62.5 ± 8.6 |
LVEF < 55%, n (%) | 33 (15.3) |
Speckle-tracking data | |
εL, % | −17.2 ± 3.6 |
εC, % | −18.6 ± 4.4 |
εR, % | 27.5 ± 8.1 |
LVEF: Left ventricular ejection fraction. CAD: Coronary artery disease εL: Global systolic longitudinal strain. εC: Global systolic circumferential strain. εR: Global systolic radial strain.